Published November 2026
Abstract
Chronic liver disease is increasingly prevalent yet often undiagnosed. The British Society of Gastroenterology (BSG) published guidance on the investigation of abnormal liver blood tests in 2000, and this was comprehensively updated in 2018. Since then, significant developments including the adoption of new nomenclature for steatotic liver disease (SLD), advances in non- invasive fibrosis assessment and expanding strategies for early detection in primary care have necessitated further revision.
This update was commissioned by the BSG Clinical Services Committee. The guideline scope was defined a priori and focused on the investigation of adults with suspected liver disease. A multidisciplinary guideline development group generated key clinical questions and conducted a systematic literature review. Recommendations were formulated using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Major updates include integration of the revised SLD terminology, updated pathways for fibrosis risk stratification, and recommendations on targeted case finding in groups at highest risk, including people with type 2 diabetes mellitus and those with harmful alcohol consumption.
Clear, evidence- based recommendations are presented for the investigation of abnormal liver blood tests, evaluation of imaging findings suggestive of liver disease, case finding among people with recognised risk factors, use of non- invasive fibrosis assessment tools and indications for referral to secondary care.
The guidelines aim to standardise diagnostic pathways, facilitate earlier detection of clinically significant liver disease, reduce unwarranted variation and support scalable models of care across primary and secondary healthcare settings.
Read Guideline Launch statement here.
LiverUK:
diagnosis primary care guide - Liver UK
Getting tested for liver disease new - Liver UK
Read the Blog post here
Abstract
Chronic liver disease is increasingly prevalent yet often undiagnosed. The British Society of Gastroenterology (BSG) published guidance on the investigation of abnormal liver blood tests in 2000, and this was comprehensively updated in 2018. Since then, significant developments including the adoption of new nomenclature for steatotic liver disease (SLD), advances in non- invasive fibrosis assessment and expanding strategies for early detection in primary care have necessitated further revision.
This update was commissioned by the BSG Clinical Services Committee. The guideline scope was defined a priori and focused on the investigation of adults with suspected liver disease. A multidisciplinary guideline development group generated key clinical questions and conducted a systematic literature review. Recommendations were formulated using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Major updates include integration of the revised SLD terminology, updated pathways for fibrosis risk stratification, and recommendations on targeted case finding in groups at highest risk, including people with type 2 diabetes mellitus and those with harmful alcohol consumption.
Clear, evidence- based recommendations are presented for the investigation of abnormal liver blood tests, evaluation of imaging findings suggestive of liver disease, case finding among people with recognised risk factors, use of non- invasive fibrosis assessment tools and indications for referral to secondary care.
The guidelines aim to standardise diagnostic pathways, facilitate earlier detection of clinically significant liver disease, reduce unwarranted variation and support scalable models of care across primary and secondary healthcare settings.
Read Guideline Launch statement here.
LiverUK:
diagnosis primary care guide - Liver UK
Getting tested for liver disease new - Liver UK
Read the Blog post here
Read More

Guidelines
Liver
BSG guidelines on the investigation of suspected liver disease in adults
clinical-resource/BSG-guidelines-on-suspected-liver-disease

EUropean consensus on the Resolution Of SympToms After oesophago-gastric Resection (EUROSTAR): Peri-Operative Quality Initiative (POQI) consensus statement
clinical-resource/EUropean-consensus-Resolution-Of-SympToms